TABLE 3.

Follow-Up Closeout Data (February 2018)

Parameter	Data
Follow-up for entire study (mo)
Median	15 (range, 2–50)
Mean ± SD	19 ± 13
Follow-up for surviving patients (mo)
Median	26 (range, 6–50)
Mean ± SD	25 ± 13
PFS
Median	10 (range, 2–50)
Mean ± SD	17 ± 14
OS
Median	16 (range, 3–50)
Mean ± SD	20 ± 13
Local or distant recurrence (n)	18 (45%)*
Death (n)	18 (45%)†

^*15 of these 18 patients died due to cancer progression.

^†During median follow-up of 11 mo (mean, 12 ± 8; range, 2–34).